This article is more than 5 years old. Information may no longer be current.

With inflammation control, pediatric IOL implantation may be performed despite uveitis

J Cataract Refract Surg. 2011;doi:10.1016/j.jcrs.2011.05.037.

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

In cases with full control of intraocular inflammation, chronic uveitis may not be a contraindication to primary IOL implantation in children, a study found.

The case series included 22 eyes of 16 patients younger than 16 years of age who underwent phacoemulsification with primary implantation of a posterior chamber IOL. Inflammation was controlled for at least 3 months before cataract surgery.

"In accordance with previous studies, we recommend this approach in selected cases. Adequate diagnosis, full control of the underlying uveitis entity, and aggressive perioperative treatment of inflammation are essential to achieving good outcomes," the study authors wrote.

After a median follow-up of 6 years, final corrected distance visual acuity was 0.3 logMAR or better in all eyes. Postop complications included two eyes with posterior capsule opacification requiring laser capsulotomy, four eyes with glaucoma and three eyes with cystoid macular edema or macular dysfunction.